OBJECTIVE: Endothelial cells (ECs), pericytes, and vascular smooth muscle cells (vSMCs) are essential for vascular development, and their dysfunction causes multiple cardiovascular diseases. Primary vascular cells for research are, however, difficult to obtain. Human-induced pluripotent stem cells (hiPSCs) derived from somatic tissue are a renewable source of ECs and vSMCs; however, their use as disease models has been limited by low and inconsistent efficiencies of differentiation and the lack of phenotypic bioassays. APPROACH AND RESULTS: Here, we developed defined conditions for simultaneous derivation of ECs and pericytes with high efficiency from hiPSCs of different tissue origin. The protocol was equally efficient for all lines and human embryonic stem cells (hESCs). The ECs could undergo sequential passage and were phenotypically indistinguishable, exhibiting features of arterial-like embryonic ECs. Moreover, hiPSC-derived ECs formed an authentic vascular plexus when cocultured with hiPSC-derived pericytes. The coculture system recapitulated (1) major steps of vascular development including EC proliferation and primary plexus remodeling, and (2) EC-mediated maturation and acquisition of contractile vSMC phenotype by pericytes. In addition, hiPSC-derived ECs integrated into developing vasculature as xenografts in zebrafish. This contrasts with more widely used ECs from human umbilical vein, which form only unstable vasculature and were completely unable to integrate into zebrafish blood vessels. CONCLUSIONS: We demonstrate that vascular derivatives of hiPSC, such as ECs and pericytes, are fully functional and can be used to study defective endothelia-pericyte interactions in vitro for disease modeling and studies on tumor angiogenesis.
OBJECTIVE: Endothelial cells (ECs), pericytes, and vascular smooth muscle cells (vSMCs) are essential for vascular development, and their dysfunction causes multiple cardiovascular diseases. Primary vascular cells for research are, however, difficult to obtain. Human-induced pluripotent stem cells (hiPSCs) derived from somatic tissue are a renewable source of ECs and vSMCs; however, their use as disease models has been limited by low and inconsistent efficiencies of differentiation and the lack of phenotypic bioassays. APPROACH AND RESULTS: Here, we developed defined conditions for simultaneous derivation of ECs and pericytes with high efficiency from hiPSCs of different tissue origin. The protocol was equally efficient for all lines and human embryonic stem cells (hESCs). The ECs could undergo sequential passage and were phenotypically indistinguishable, exhibiting features of arterial-like embryonic ECs. Moreover, hiPSC-derived ECs formed an authentic vascular plexus when cocultured with hiPSC-derived pericytes. The coculture system recapitulated (1) major steps of vascular development including EC proliferation and primary plexus remodeling, and (2) EC-mediated maturation and acquisition of contractile vSMC phenotype by pericytes. In addition, hiPSC-derived ECs integrated into developing vasculature as xenografts in zebrafish. This contrasts with more widely used ECs from human umbilical vein, which form only unstable vasculature and were completely unable to integrate into zebrafish blood vessels. CONCLUSIONS: We demonstrate that vascular derivatives of hiPSC, such as ECs and pericytes, are fully functional and can be used to study defective endothelia-pericyte interactions in vitro for disease modeling and studies on tumor angiogenesis.
Authors: Gaurav Kaushik; Daniel A Gil; Elizabeth Torr; Elizabeth S Berge; Cheryl Soref; Peyton Uhl; Gianluca Fontana; Jessica Antosiewicz-Bourget; Collin Edington; Michael P Schwartz; Linda G Griffith; James A Thomson; Melissa C Skala; William T Daly; William L Murphy Journal: Adv Healthc Mater Date: 2018-12-19 Impact factor: 9.933
Authors: Jue Zhang; Li-Fang Chu; Zhonggang Hou; Michael P Schwartz; Timothy Hacker; Vernella Vickerman; Scott Swanson; Ning Leng; Bao Kim Nguyen; Angela Elwell; Jennifer Bolin; Matthew E Brown; Ron Stewart; William J Burlingham; William L Murphy; James A Thomson Journal: Proc Natl Acad Sci U S A Date: 2017-07-10 Impact factor: 11.205
Authors: Cody O Crosby; Deepti Valliappan; David Shu; Sachin Kumar; Chengyi Tu; Wei Deng; Sapun H Parekh; Janet Zoldan Journal: Tissue Eng Part A Date: 2019-05-02 Impact factor: 3.845
Authors: Gina M Mosich; Regina Husman; Paras Shah; Abhinav Sharma; Kevin Rezzadeh; Temidayo Aderibigbe; Vivian J Hu; Daniel J McClintick; Genbin Wu; Jonathan D Gatto; Haibin Xi; April D Pyle; Bruno Péault; Frank A Petrigliano; Ayelet Dar Journal: JCI Insight Date: 2019-12-19
Authors: Helena Vazão; Susana Rosa; Tânia Barata; Ricardo Costa; Patrícia R Pitrez; Inês Honório; Margreet R de Vries; Dimitri Papatsenko; Rui Benedito; Daniel Saris; Ali Khademhosseini; Paul H A Quax; Carlos F Pereira; Nadia Mercader; Hugo Fernandes; Lino Ferreira Journal: Proc Natl Acad Sci U S A Date: 2017-03-27 Impact factor: 11.205
Authors: Ivan Carcamo-Orive; Ngan F Huang; Thomas Quertermous; Joshua W Knowles Journal: Arterioscler Thromb Vasc Biol Date: 2017-07-20 Impact factor: 8.311
Authors: Johannes Bargehr; Lucinda Low; Christine Cheung; William G Bernard; Dharini Iyer; Martin R Bennett; Laure Gambardella; Sanjay Sinha Journal: Stem Cells Transl Med Date: 2016-05-18 Impact factor: 6.940